U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H13N3O4
Molecular Weight 263.2493
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OLAQUINDOX

SMILES

CC1=[N+]([O-])C2=CC=CC=C2[N+]([O-])=C1C(=O)NCCO

InChI

InChIKey=TURHTASYUMWZCC-UHFFFAOYSA-N
InChI=1S/C12H13N3O4/c1-8-11(12(17)13-6-7-16)15(19)10-5-3-2-4-9(10)14(8)18/h2-5,16H,6-7H2,1H3,(H,13,17)

HIDE SMILES / InChI

Molecular Formula C12H13N3O4
Molecular Weight 263.2493
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Olaquindox, a potent antibacterial agent, is used as an effective feed additive in the livestock industry. Olaquindox could potentially expose a human to the risk of biological hazards due to its genotoxicity and cytotoxicity. However, the potential mechanism of toxicity is still unknown. Recently was provided experiments to explore the molecular mechanism of p21 on olaquindox-induced mitochondrial apoptosis. It was shown, that olaquindox promoted the production of ROS, suppressed the protein expression p21 in a p53-independent way and phosphorylated p21. This experiment provided new insights into the molecular mechanism of olaquindox and shed light on the role of p21.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro.
2010 May 14
Patents

Sample Use Guides

Subchronic oral toxicity study in rats: olaquindox (150 mg/kg), approximately equivalent to 15 mg/kg b.w./day, for 13 weeks
Route of Administration: Oral
It was deciphered the detrimental effects of olaquindox on male fertility by mechanistically unraveling how olaquindox intervenes blood-testis barrier in mouse. Olaquindox (400 μg/ml) exposure significantly compromised tight junction permeability function, decreased or dislocated the junction proteins (e.g., ZO-1, occludin and N-cadherin) and attenuated mTORC2 signaling pathway in primary Sertoli cells. Furthermore, olaquindox disrupted F-actin architecture through interfering with the expression of actin branching protein complex (CDC42-N-WASP-Arp3) and actin bunding protein palladin. Olaquindox also triggered severely DNA damage and apoptosis while inhibiting autophagic flux in Sertoli cell presumably due to the exacerbated generation of reactive oxygen species (ROS).
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:55:45 GMT 2023
Edited
by admin
on Fri Dec 15 15:55:45 GMT 2023
Record UNII
G3LAW9U88T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OLAQUINDOX
HSDB   INN   MART.   MI  
INN  
Official Name English
BAY-VA-9391
Code English
OLAQUINDOX [MI]
Common Name English
N-(2-HYDROXYETHYL)-3-METHYL-2-QUINOXALINECARBOXAMIDE 1,4-DIOXIDE
Systematic Name English
OLAQUINDOX [HSDB]
Common Name English
BAY VA 9391
Code English
olaquindox [INN]
Common Name English
OLAQUINDOX [MART.]
Common Name English
Classification Tree Code System Code
WHO-VATC QJ01MQ01
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
NCI_THESAURUS C271
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
Code System Code Type Description
INN
3536
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
EPA CompTox
DTXSID3040726
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
MERCK INDEX
m8186
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C90736
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
ChEMBL
CHEMBL1649716
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
EVMPD
SUB09427MIG
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
SMS_ID
100000083312
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
FDA UNII
G3LAW9U88T
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
HSDB
7025
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
CAS
23696-28-8
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
PUBCHEM
71905
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
ECHA (EC/EINECS)
245-832-7
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
MESH
C013168
Created by admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY